Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,092,998
  • Shares Outstanding, K 189,880
  • Annual Sales, $ 2,419 M
  • Annual Income, $ 167,650 K
  • 60-Month Beta 0.32
  • Price/Sales 7.07
  • Price/Cash Flow 50.32
  • Price/Book 3.23
Trade BMRN with:

Options Overview Details

View History
  • Implied Volatility 31.52% ( -0.35%)
  • Historical Volatility 32.83%
  • IV Percentile 71%
  • IV Rank 35.04%
  • IV High 48.42% on 08/05/24
  • IV Low 22.40% on 11/03/23
  • Put/Call Vol Ratio 1.76
  • Today's Volume 342
  • Volume Avg (30-Day) 2,067
  • Put/Call OI Ratio 1.12
  • Today's Open Interest 50,763
  • Open Int (30-Day) 45,293

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.55
  • Number of Estimates 11
  • High Estimate 0.62
  • Low Estimate 0.50
  • Prior Year 0.26
  • Growth Rate Est. (year over year) +111.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
80.06 +12.44%
on 08/05/24
94.85 -5.09%
on 08/20/24
+5.59 (+6.62%)
since 07/23/24
3-Month
73.68 +22.19%
on 05/30/24
94.85 -5.09%
on 08/20/24
+14.12 (+18.60%)
since 05/23/24
52-Week
73.68 +22.19%
on 05/30/24
99.56 -9.58%
on 12/14/23
-1.05 (-1.15%)
since 08/23/23

Most Recent Stories

More News
Stock Index Futures Tread Water as Investors Brace for Fed Minutes and Powell’s Speech

September S&P 500 E-Mini futures (ESU24) are up +0.01%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.09% this morning as market participants geared up for the release of the minutes of the...

ESU24 : 5,652.50s (+1.05%)
NQU24 : 19,790.75s (+1.09%)
ZIM : 20.17 (-4.99%)
AMD : 154.98 (+2.16%)
MCD : 289.52 (+0.11%)
HPQ : 35.66 (+1.65%)
LOW : 250.07 (+4.06%)
MDT : 88.35 (+0.59%)
KEYS : 155.01 (+0.24%)
TOL : 148.72 (+5.27%)
AS : 14.12 (+2.10%)
TTNP : 6.13 (-23.37%)
CSX, Caterpillar rise; ZoomInfo, Teradata fall, Tuesday, 8/6/2024

Stocks that traded heavily or had substantial price changes on Tuesday: CSX, Caterpillar rise; ZoomInfo, Teradata fall

YUMC : 33.37 (-1.18%)
LCID : 4.20 (+9.09%)
BMRN : 90.02 (unch)
PLTR : 31.78 (-0.44%)
CSX : 33.69 (+1.38%)
TDC : 28.13 (+1.92%)
ZI : 9.72 (+2.21%)
BioMarin: Q2 Earnings Snapshot

BioMarin: Q2 Earnings Snapshot

BMRN : 90.02 (unch)
4 Incomparable Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Plain-as-day bargains can still be found, even with the innovation-fueled Nasdaq Composite powering to a fresh all-time high.

COMP : 5.13 (+9.38%)
$NASX : 17,877.79 (+1.47%)
META : 528.00 (-0.74%)
FVRR : 26.60 (+0.53%)
BMRN : 90.02 (unch)
WDC : 64.35 (+0.48%)
4 Dominant Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Opportunistic investors can still find bargains, even with the Nasdaq Composite up 49% since the start of 2023.

COMP : 5.13 (+9.38%)
$NASX : 17,877.79 (+1.47%)
INTC : 20.54 (+2.19%)
BMRN : 90.02 (unch)
S : 25.26 (+2.85%)
PYPL : 71.70 (+0.25%)
BioMarin: Q1 Earnings Snapshot

BioMarin: Q1 Earnings Snapshot

BMRN : 90.02 (unch)
4 Extraordinary Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

Although the Nasdaq Composite is galloping to record highs, amazing deals among growth stocks can still be uncovered.

COMP : 5.13 (+9.38%)
$NASX : 17,877.79 (+1.47%)
PYPL : 71.70 (+0.25%)
FVRR : 26.60 (+0.53%)
BMRN : 90.02 (unch)
GOOGL : 165.62 (+1.11%)
GOOG : 167.43 (+1.17%)
BioMarin: Q4 Earnings Snapshot

BioMarin: Q4 Earnings Snapshot

BMRN : 90.02 (unch)
3 No-Brainer Stocks to Buy With $200 Right Now

A reasonably small amount of money can go a long way when it's put to work in innovative, industry-leading businesses.

NEE : 79.66 (+0.94%)
BMRN : 90.02 (unch)
PM : 120.15 (+0.04%)
New Era at Elliott: Appointing Partners to Spearhead Diverse Investments

Elliott Investment Management, the renowned activist investment firm founded by billionaire Paul Singer, is enhancing its leadership with the appointment of three new partners. In a strategic move, Elliott...

CCI : 112.38 (+2.64%)
PINS : 32.34 (+1.00%)
ETSY : 55.40 (+2.99%)
PSX : 135.37 (+1.66%)
GT : 8.89 (+4.71%)
BMRN : 90.02 (unch)
STZ : 245.18 (+0.61%)
CRM : 264.00 (+2.09%)
CTXS : 103.90 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 92.17
2nd Resistance Point 91.48
1st Resistance Point 90.75
Last Price 90.02
1st Support Level 89.33
2nd Support Level 88.64
3rd Support Level 87.91

See More

52-Week High 99.56
Last Price 90.02
Fibonacci 61.8% 89.67
Fibonacci 50% 86.62
Fibonacci 38.2% 83.56
52-Week Low 73.68

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar